biological synthesis of zno nanoparticles using c. albicans and studying their catalytic performance in the synthesis of steroidal pyrazolines

Clicks: 287
ID: 151853
2017
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #43 of 167 articles by views in Behavioural brain research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 167 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
In this study, we describe a green and simple procedure for biosynthesis of ZnO nanoparticles using Candida albicans as eco-friendly reducing and capping agent. The synthesized ZnO nanoparticles were characterized by UV–vis spectroscopy, powder X-ray diffraction, scanning electron microscopy (SEM), transmission electron microscopy (TEM), photoluminescence (PL), thermo gravimetric analysis (TGA) and differential thermal analysis (DTA). The prepared nano-particles were used as catalyst for the fast and efficient synthesis of steroidal pyrazolines (4–9) from α, β-unsaturated steroidal ketones (1–3). The target molecules were obtained in good to excellent yields applying the current method.
Reference Key
shamsuzzaman2017arabianbiological Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Shamsuzzaman;Ashraf Mashrai;Hena Khanam;Rezq Naji Aljawfi
Journal Behavioural brain research
Year 2017
DOI
10.1016/j.arabjc.2013.05.004
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.